---
title: "Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injectio... — FDA record D-0325-2024 | Is It on Recall"
description: "Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date."
url: https://isitonrecall.com/recall/fda-drug-d-0325-2024-vasopressin-2-units-2-ml-in-0-9-sodium-chloride-sterile-syringe-for-injection-concentration-1-unit-m/
updated: 2026-10-01
site: "Is It on Recall"
language: en
---

[Recall archive](https://isitonrecall.com/archives/) / FDA drug enforcement

# Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syring... — FDA record D-0325-2024

Reported ongoing

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jan 22, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/).

## What the record says

- **Product**: Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.
- **Reason**: Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
- **Classification**: Class II
- **Recalling firm**: IntegraDose Compounding Services LLC
- **Quantity**: 1,299 syringes
- **Agency-reported status**: Ongoing
- **Source record identifier**: D-0325-2024

[Open the official record](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0325-2024%22)

[What the recall classes mean](https://isitonrecall.com/guides/recall-classes/). Classification is an agency assessment, not individual medical advice.

## Lot and product identifiers

| Label field | Details supplied by the agency |
| --- | --- |
| Lot, code or applicability | Lot #s: 20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024 |

Match all identifying details in the current notice. A brand name alone is not enough.

## Distribution

MN

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

- [Minnesota](https://isitonrecall.com/state/minnesota/)

## Dates in the source

- **Report date**: Feb 21, 2024
- **Recall initiation date**: Jan 22, 2024
- **Center classification date**: Feb 15, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

## What to do next

Read the official notice for the action that applies to your exact product.

[Read the current instructions](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0325-2024%22)

## Before changing a medicine

Follow urgent instructions in the current official recall notice. Speak to your pharmacist or prescriber before stopping or changing a prescribed medicine.

Talk to your doctor or pharmacist if you have questions or concerns about your medicine. [FDA medication recall guidance](https://www.fda.gov/drugs/drug-recalls/understanding-drug-recalls-what-know-and-what-do)

## Related records

[Medications records](https://isitonrecall.com/category/medications/) [IntegraDose Compounding Services LLC records](https://isitonrecall.com/brand/integradose-compounding-services-llc/)